Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
2
×
life sciences
national blog main
alirocumab
alnylam pharmaceuticals
amgen
bempedoic acid
boston blog main
boston top stories
cholesterol
corticosteroids
deals
detroit
detroit blog main
detroit top stories
esperion therapeutics
evolocumab
ezetimibe
fluoroquinolones
inclisiran
national top stories
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
statins
the medicines company
tim mayleben
What
cholesterol
2
×
drug
fda
medicines
acquire
agreed
approved
billion
brings
cash
combo
company
compound
deal
esperion
esperion’s
levels
lowering
medco
new
nod
novartis
pairs
pill
poised
ready
regulatory
second
single
therapeutics
wave
wins
Language
unset
Current search:
cholesterol
×
fda
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
